{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:02:54Z","timestamp":1791327774366,"version":"4.3.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ejpb.2021.04.007","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T03:18:27Z","timestamp":1618456707000},"page":"223-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"special_numbering":"C","title":["Combinatorial lipid-nanosystem for dermal delivery of 5-fluorouracil and resveratrol against skin cancer: Delineation of improved dermatokinetics and epidermal drug deposition enhancement analysis"],"prefix":"10.1016","volume":"163","author":[{"given":"Mohammad Kashif","family":"Iqubal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashif","family":"Iqubal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Imtiyaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Moshahid A.","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madan Mohan","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjula","family":"Baboota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2021.04.007_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/2606271","article-title":"Skin cancer and its treatment: novel treatment approaches with emphasis on nanotechnology","volume":"2017","author":"Orthaber","year":"2017","journal-title":"J. Nanomater."},{"key":"10.1016\/j.ejpb.2021.04.007_b0010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4155\/tde-2016-0093","article-title":"Skin cancer: symptoms, mechanistic pathways and treatment rationale for therapeutic delivery","volume":"8","author":"Goyal","year":"2017","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejpb.2021.04.007_b0015","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jaad.2007.01.033","article-title":"Nonmelanoma skin cancer","volume":"57","author":"Ridky","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejpb.2021.04.007_b0020","doi-asserted-by":"crossref","unstructured":"G. Micali, F. Lacarrubba, M.R. Nasca, S. Ferraro, R.A. Schwartz, Topical pharmacotherapy for skin cancer: Part II. Clinical applications, J. Am. Acad. Dermatol. 70 (2014) 979.e1-979.e12. https:\/\/doi.org\/10.1016\/j.jaad.2013.12.037.","DOI":"10.1016\/j.jaad.2013.12.037"},{"key":"10.1016\/j.ejpb.2021.04.007_b0025","doi-asserted-by":"crossref","unstructured":"V.M. Voiculescu, C.V. Lisievici, M. Lupu, C. Vajaitu, C.C. Draghici, A.V. Popa, I. Solomon, T.I. Sebe, M.M. Constantin, C. Caruntu, Mediators of inflammation in topical therapy of skin cancers, Mediators Inflamm. Article ID (2019) 1\u201315. https:\/\/doi.org\/10.1155\/2019\/8369690.","DOI":"10.1155\/2019\/8369690"},{"key":"10.1016\/j.ejpb.2021.04.007_b0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/424239","article-title":"Novel resveratrol and 5-fluorouracil coencapsulated in PEGylated nanoliposomes improve chemotherapeutic efficacy of combination against head and neck squamous cell carcinoma","volume":"2014","author":"Mohan","year":"2014","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.ejpb.2021.04.007_b0035","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.3748\/wjg.v10.i20.3048","article-title":"Effect of resveratrol and in combination with 5-FU on murine liver cancer","volume":"10","author":"Wu","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejpb.2021.04.007_b0040","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.3892\/mmr.2015.3675","article-title":"Anti-angiogenic effects of resveratrol in combination with 5-fluorouracil on B16 murine melanoma cells","volume":"12","author":"Lee","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejpb.2021.04.007_b0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bcp.2015.08.105","article-title":"Resveratrol induces chemosensitization to 5-fluorouracil through up-regulation of intercellular junctions, epithelial-to-mesenchymal transition and apoptosis in colorectal cancer","volume":"98","author":"Buhrmann","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejpb.2021.04.007_b0050","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1208\/s12249-014-0103-1","article-title":"Development of novel ionic liquid-based microemulsion formulation for dermal delivery of 5-fluorouracil","volume":"15","author":"Goindi","year":"2014","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejpb.2021.04.007_b0055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3329\/icpj.v3i7.19079","article-title":"Process optimisation, characterisation and evaluation of resveratrol-phospholipid complexes using Box-Behnken statistical design","volume":"3","author":"Agarwal","year":"2014","journal-title":"Int. Curr. Pharm. J."},{"key":"10.1016\/j.ejpb.2021.04.007_b0060","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1021\/acs.molpharmaceut.8b00047","article-title":"Fluorouracil-loaded gold nanoparticles for the treatment of skin cancer: development, in vitro characterization, and in vivo evaluation in a mouse skin cancer xenograft model","volume":"15","author":"Safwat","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2021.04.007_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12020108","article-title":"Novel nanocarriers for targeted topical skin delivery of the antioxidant resveratrol","volume":"12","author":"Nastiti","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2021.04.007_b0070","first-page":"89","article-title":"Nanostructure lipid carriers: a modish contrivance to overcome the ultraviolet effects, Egypt","volume":"4","author":"Jain","year":"2017","journal-title":"J. Basic Appl. Sci."},{"key":"10.1016\/j.ejpb.2021.04.007_b0075","doi-asserted-by":"crossref","unstructured":"N.Y. Nandvikar, R.R. Lala, A.S. Shinde, Nanostructured lipid carrier: The advanced lipid carriers, 10 (2019) 5252\u20135265. https:\/\/doi.org\/10.13040\/IJPSR.0975-8232.10(12).5252-65.","DOI":"10.13040\/IJPSR.0975-8232.10(12).5252-65"},{"key":"10.1016\/j.ejpb.2021.04.007_b0080","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pharep.2018.10.008","article-title":"Nanostructured lipid carriers: a potential use for skin drug delivery systems","volume":"71","author":"Czajkowska-Ko\u015bnik","year":"2019","journal-title":"Pharmacol. Reports."},{"key":"10.1016\/j.ejpb.2021.04.007_b0085","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3109\/03639045.2014.950586","article-title":"Nanostructured lipid carriers based nanogel for meloxicam delivery: mechanistic, in-vivo and stability evaluation","volume":"41","author":"Khurana","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2021.04.007_b0090","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ejpb.2016.07.026","article-title":"Nanostructured lipid carriers for the topical delivery of tretinoin","volume":"108","author":"Ghate","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2021.04.007_b0095","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jddst.2015.10.003","article-title":"From nanoemulsions to nanostructured lipid carriers: a relevant development in dermal delivery of drugs and cosmetics","volume":"32","author":"Montenegro","year":"2016","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2021.04.007_b0100","doi-asserted-by":"crossref","unstructured":"Y.-K. Lin, Z.-R. Huang, R.-Z. Zhuo, J.-Y. Fang, Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery., Int. J. Nanomedicine. 5 (2010) 117\u201328. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20309398%0Ahttp:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=PMC2841490.","DOI":"10.2147\/IJN.S9155"},{"key":"10.1016\/j.ejpb.2021.04.007_b0105","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2174\/1573411016999200619184403","article-title":"Development and validation of a robust HPLC method for simultaneous estimation of 5-fluorouracil and resveratrol and its application in the engineered nanostructured lipid carrier","volume":"17","author":"Iqubal","year":"2021","journal-title":"Curr. Anal. Chem."},{"key":"10.1016\/j.ejpb.2021.04.007_b0110","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3109\/10717544.2016.1165310","article-title":"Nanostructured lipid carrier in photodynamic therapy for the treatment of basal-cell carcinoma","volume":"23","author":"Qidwai","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2021.04.007_b0115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bfopcu.2015.10.001","article-title":"Nanostructured lipid carrier system for topical delivery of terbinafine hydrochloride","volume":"53","author":"Gaba","year":"2015","journal-title":"Bull. Fac. Pharmacy, Cairo Univ."},{"key":"10.1016\/j.ejpb.2021.04.007_b0120","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.colsurfb.2009.11.021","article-title":"Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe","volume":"76","author":"Bali","year":"2010","journal-title":"Colloids Surfaces B Biointerfaces."},{"key":"10.1016\/j.ejpb.2021.04.007_b0125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejpb.2016.07.017","article-title":"Tacrolimus-loaded nanostructured lipid carriers for oral delivery \u2013 optimization of production and characterization","volume":"108","author":"Khan","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2021.04.007_b0130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijpharm.2013.12.006","article-title":"Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers","volume":"461","author":"Negi","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.04.007_b0135","first-page":"177","article-title":"Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability","volume":"8","author":"Neves","year":"2013","journal-title":"Int. J. Nanomedicine."},{"key":"10.1016\/j.ejpb.2021.04.007_b0140","first-page":"1049","article-title":"Nanostructured lipid carriers as a novel oral delivery system for triptolide: Induced changes in pharmacokinetics profile associated with reduced toxicity in male rats","volume":"9","author":"Zhang","year":"2014","journal-title":"Int. J. Nanomedicine."},{"key":"10.1016\/j.ejpb.2021.04.007_b0145","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.molliq.2018.01.141","article-title":"Silymarin loaded nanostructured lipid carrier: From design and dermatokinetic study to mechanistic analysis of epidermal drug deposition enhancement","volume":"255","author":"Iqbal","year":"2018","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ejpb.2021.04.007_b0150","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1080\/03639045.2016.1190743","article-title":"Doxorubicin- and cisplatin-loaded nanostructured lipid carriers for breast cancer combination chemotherapy","volume":"42","author":"Di","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2021.04.007_b0155","first-page":"1","article-title":"Nanostructured lipid carriers: a review journal of developing drugs","volume":"7","author":"Sharma","year":"2018","journal-title":"J. Dev. Drugs."},{"key":"10.1016\/j.ejpb.2021.04.007_b0160","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.biopha.2018.04.055","article-title":"Nanostructured lipid carriers for site-specific drug delivery","volume":"103","author":"Khosa","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejpb.2021.04.007_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12010006","article-title":"Sulforaphane-loaded ultradeformable vesicles as a potential natural nanomedicine for the treatment of skin cancer diseases","volume":"12","author":"Cristiano","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2021.04.007_b0170","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s10973-017-6394-1","article-title":"DSC for evaluating the encapsulation efficiency of lidocaine-loaded liposomes compared to the ultracentrifugation method","volume":"130","author":"Bakonyi","year":"2017","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.ejpb.2021.04.007_b0175","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jconrel.2016.09.007","article-title":"Improved topical delivery of tacrolimus: a novel composite hydrogel formulation for the treatment of psoriasis","volume":"242","author":"Gabriel","year":"2016","journal-title":"J. Control. Release."},{"key":"10.1016\/j.ejpb.2021.04.007_b0180","doi-asserted-by":"crossref","unstructured":"R. Lifshiz Zimon, G. Lerman, E. Elharrar, T. Meningher, A. Barzilai, M. Masalha, R. Chintakunta, E. Hollander, R. Goldbart, T. Traitel, M. Harats, Y. Sidi, D. Avni, J. Kost, Ultrasound targeting of Q-starch\/miR-197 complexes for topical treatment of psoriasis, J. Control. Release. 284 (2018) 103\u2013111. https:\/\/doi.org\/10.1016\/j.jconrel.2018.05.040.","DOI":"10.1016\/j.jconrel.2018.05.040"},{"key":"10.1016\/j.ejpb.2021.04.007_b0185","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijpharm.2003.10.038","article-title":"Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge","volume":"275","author":"Kohli","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.04.007_b0190","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijpharm.2018.08.062","article-title":"Multifunctional carbamazepine loaded nanostructured lipid carrier (NLC) formulation","volume":"550","author":"Elmowafy","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.04.007_b0195","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.2147\/IJN.S108694","article-title":"Nanostructured lipid carriers loaded with resveratrol modulate human dendritic cells","volume":"11","author":"Barbosa","year":"2016","journal-title":"Int. J. Nanomedicine."},{"key":"10.1016\/j.ejpb.2021.04.007_b0200","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1080\/10717544.2018.1529209","article-title":"Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy","volume":"25","author":"Cirri","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2021.04.007_b0205","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/08982104.2016.1149866","article-title":"Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate","volume":"27","author":"Abdel-Salam","year":"2017","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ejpb.2021.04.007_b0210","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jsps.2012.11.005","article-title":"Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia","volume":"21","author":"Uprit","year":"2013","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.ejpb.2021.04.007_b0215","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11030140","article-title":"Mathematical modeling of release kinetics from supramolecular drug delivery systems","volume":"11","author":"Mircioiu","year":"2019","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejpb.2021.04.007_b0220","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.2147\/IJN.S117511","article-title":"Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil","volume":"11","author":"Rajinikanth","year":"2016","journal-title":"Int. J. Nanomedicine."},{"key":"10.1016\/j.ejpb.2021.04.007_b0225","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s13346-016-0291-1","article-title":"Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization","volume":"6","author":"Nagaich","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2021.04.007_b0230","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/21691401.2018.1469025","article-title":"Development of transethosomes formulation for dermal fisetin delivery: Box-Behnken design, optimization, in vitro skin penetration, vesicles\u2013skin interaction and dermatokinetic studies","volume":"46","author":"Moolakkadath","year":"2018","journal-title":"Artif. Cells, Nanomedicine Biotechnol."},{"key":"10.1016\/j.ejpb.2021.04.007_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-019-1360-9","article-title":"Cocrystal of 5-fluorouracil: characterization and evaluation of biopharmaceutical parameters","volume":"20","author":"Gautam","year":"2019","journal-title":"AAPS PharmSciTech."},{"key":"10.1016\/j.ejpb.2021.04.007_b0240","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.biopha.2017.01.083","article-title":"Niosome-based hydrogel of resveratrol for topical applications: an effective therapy for pain related disorder(s)","volume":"88","author":"Negi","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejpb.2021.04.007_b0245","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s13346-019-00616-3","article-title":"Nano-engineered lipid-polymer hybrid nanoparticles of fusidic acid: an investigative study on dermatokinetics profile and MRSA-infected burn wound model","volume":"9","author":"Thakur","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2021.04.007_b0250","doi-asserted-by":"crossref","unstructured":"M. Mir, N. Ahmed, A.D. Permana, A.M. Rodgers, R.F. Donnelly, A. ur. Rehman, Enhancement in Site-Specific Delivery of Carvacrol against Methicillin Resistant Staphylococcus aureus Induced Skin Infections Using Enzyme Responsive Nanoparticles: A Proof of Concept Study, Pharmaceutics. 11 (2019) 1\u201324. https:\/\/doi.org\/10.3390\/pharmaceutics11110606.","DOI":"10.3390\/pharmaceutics11110606"},{"key":"10.1016\/j.ejpb.2021.04.007_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119125","article-title":"Preparation and optimization of fisetin loaded glycerol based soft nanovesicles by Box-Behnken design","volume":"578","author":"Moolakkadath","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.04.007_b0260","first-page":"1473","article-title":"Nanoemulsion loaded gel for topical co-delivery of clobitasol propionate and calcipotriol in psoriasis, Nanomedicine Nanotechnology","volume":"13","author":"Kaur","year":"2017","journal-title":"Biol. Med."},{"key":"10.1016\/j.ejpb.2021.04.007_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119705","article-title":"Topical nanostructured lipid carrier gel of quercetin and resveratrol: Formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer","volume":"587","author":"Imran","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.04.007_b0270","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2147\/IJN.S186899","article-title":"Preparation and characterization of nimodipine-loaded nanostructured lipid systems for enhanced solubility and bioavailability","volume":"14","author":"Teng","year":"2019","journal-title":"Int. J. Nanomedicine."},{"key":"10.1016\/j.ejpb.2021.04.007_b0275","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.apsb.2014.10.005","article-title":"Solid lipid nanoparticles for nose to brain delivery of haloperidol: in vitro drug release and pharmacokinetics evaluation","volume":"4","author":"Yasir","year":"2014","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.ejpb.2021.04.007_b0280","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jconrel.2019.08.008","article-title":"Labrasol\u00ae is an efficacious intestinal permeation enhancer across rat intestine: Ex vivo and in vivo rat studies","volume":"310","author":"McCartney","year":"2019","journal-title":"J. Control. Release."},{"key":"10.1016\/j.ejpb.2021.04.007_b0285","series-title":"Nanostructures Cancer Ther","first-page":"653","article-title":"Self-emulsifying delivery systems: one step ahead in improving solubility of poorly soluble drugs","author":"Chavda","year":"2017"},{"key":"10.1016\/j.ejpb.2021.04.007_b0290","unstructured":"M.C.F. Rodr\u00edguez, Stabilizing composition for topical application formulations and using the same., ES2377616B1, 2010. https:\/\/patents.google.com\/patent\/ES2377616B1\/en."},{"key":"10.1016\/j.ejpb.2021.04.007_b0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1088\/0957-4484\/27\/43\/435101","article-title":"Design Expert\u00ae supported optimization and predictive analysis of selegiline nanoemulsion via the olfactory region with enhanced behavioural performance in Parkinson\u2019s disease","volume":"27","author":"Kumar","year":"2016","journal-title":"Nanotechnology."},{"key":"10.1016\/j.ejpb.2021.04.007_b0300","unstructured":"EMA\/CHMP, Information for the package leaflet regarding polysorbates used as excipients in medicinal products for human use, Eur. Med. Agency. Commitee Med. Prod. Hum. Use. 44 (2018) 1\u201342."},{"key":"10.1016\/j.ejpb.2021.04.007_b0305","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1158\/0008-5472.CAN-03-3391","article-title":"Taxane-mediated antiangiogenesis in vitro: influence of formulation vehicles and binding proteins","volume":"64","author":"Ng","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejpb.2021.04.007_b0310","first-page":"1341","article-title":"Treatment of reticulum cell sarcoma in SJL\/J mice with Tween 80","volume":"8","author":"Crispens","year":"1988","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejpb.2021.04.007_b0315","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijpharm.2010.12.036","article-title":"Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): Effects on size, physical stability and particle matrix structure","volume":"406","author":"Kovacevic","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.04.007_b0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics11060284","article-title":"Ucu\u00f9ba (Virola surinamensis) fat-based nanostructured lipid carriers for nail drug delivery of ketoconazole: development and optimization using box-behnken design","volume":"11","author":"Pereira","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2021.04.007_b0325","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(02)00180-1","article-title":"Nanostructured lipid matrices for improved microencapsulation of drugs","volume":"242","author":"M\u00fcller","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.04.007_b0330","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/1541-4337.12189","article-title":"Formation of food-grade nanoemulsions using low-energy preparation methods: a review of available methods","volume":"15","author":"Komaiko","year":"2016","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"10.1016\/j.ejpb.2021.04.007_b0335","series-title":"Nanobiomaterials Cancer Ther","first-page":"1","article-title":"Nanopreparations for skin cancer therapy","author":"Campos","year":"2016"},{"key":"10.1016\/j.ejpb.2021.04.007_b0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejpb.2021.04.007_b0345","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1517\/17425240802712590","article-title":"Nanostructured lipid carrier-based hydrogel formulations for drug delivery: a comprehensive review","volume":"6","author":"Doktorovova","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2021.04.007_b0350","first-page":"1","article-title":"BBD-based development of itraconazole loaded nanostructured lipid carrier for topical delivery. in vitro evaluation and antimicrobial assessment","author":"Ameeduzzafar","year":"2020","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.ejpb.2021.04.007_b0355","doi-asserted-by":"crossref","first-page":"7638","DOI":"10.20964\/2017.08.27","article-title":"Investigation of some nonionic surfactants as corrosion inhibitors for carbon steel in sulfuric acid medium","volume":"12","author":"Branzoi","year":"2017","journal-title":"Int. J. Electrochem. Sci."},{"key":"10.1016\/j.ejpb.2021.04.007_b0360","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.colsurfb.2016.04.042","article-title":"Sustained release of melatonin: a novel approach in elevating efficacy of tamoxifen in breast cancer treatment","volume":"145","author":"Sabzichi","year":"2016","journal-title":"Colloids Surfaces B Biointerfaces."},{"key":"10.1016\/j.ejpb.2021.04.007_b0365","doi-asserted-by":"crossref","unstructured":"A. zur M\u00fchlen, C. Schwarz, W. Mehnert, Solid lipid nanoparticles (SLN) for controlled drug delivery \u2013 Drug release and release mechanism, Eur. J. Pharm. Biopharm. 45 (1998) 149\u2013155. https:\/\/doi.org\/10.1016\/S0939-6411(97)00150-1.","DOI":"10.1016\/S0939-6411(97)00150-1"},{"key":"10.1016\/j.ejpb.2021.04.007_b0370","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0168-3659(02)00057-3","article-title":"Terpenes in ethanol: haloperidol permeation and partition through human skin and stratum corneum changes","volume":"81","author":"Vaddi","year":"2002","journal-title":"J. Control. Release."},{"key":"10.1016\/j.ejpb.2021.04.007_b0375","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijpharm.2016.05.005","article-title":"In-vivo dermal pharmacokinetics, efficacy, and safety of skin targeting nanoparticles for corticosteroid treatment of atopic dermatitis","volume":"507","author":"Siddique","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.04.007_b0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13005-016-0106-0","article-title":"Basal cell carcinoma, squamous cell carcinoma and melanoma of the head and face","volume":"12","author":"Feller","year":"2016","journal-title":"Head Face Med."},{"key":"10.1016\/j.ejpb.2021.04.007_b0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2015.04.056","article-title":"Ultradeformable liposomes as multidrug carrier of resveratrol and 5-fluorouracil for their topical delivery","volume":"489","author":"Cosco","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.04.007_b0390","doi-asserted-by":"crossref","first-page":"32943","DOI":"10.18632\/oncotarget.25993","article-title":"Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells","volume":"9","author":"Chung","year":"2018","journal-title":"Oncotarget."},{"key":"10.1016\/j.ejpb.2021.04.007_b0395","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1177\/1535370215573396","article-title":"Resveratrol synergistically augments anti-tumor effect of 5-FU in vitro and in vivo by increasing S-phase arrest and tumor apoptosis","volume":"240","author":"Dun","year":"2015","journal-title":"Exp. Biol. Med."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121000989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121000989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:45:36Z","timestamp":1760546736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641121000989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":79,"alternative-id":["S0939641121000989"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.04.007","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combinatorial lipid-nanosystem for dermal delivery of 5-fluorouracil and resveratrol against skin cancer: Delineation of improved dermatokinetics and epidermal drug deposition enhancement analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}